Congratulations to Dr. Julia Burnier! Â鶹AV and Moderna are expanding collaborations with new projects in Lipid Nanoparticle research, and Dr. Burnier's project is one of two Â鶹AV projects selected for funding by Moderna. Dr. Burnier, Assistant Professor of Pathology, is investigating ways to enhance the cell-specific delivery of cargo like mRNA. Extracellular vesicles (EVs) are naturally occurring nanoparticles that are released by virtually all cells and can deliver cargo to specific cells. Her research aims to develop a cell delivery system using microfluidics that emulates the activity of EVs, which could help optimize delivery to targeted recipient cells. This offers the possibility of developing therapies beyond vaccines, such as in precision oncology and other illnesses. The project is scheduled to run for three years.
Learn more .